Drug Trial Radar · NCT05252117
Uterovaginal Plexus Block With Articaine for Intrauterine Device Placement Patients Who Are Indicated for the Use of Copper IUD as a Contraceptive Method Will be Invited to Participate in This Research.
Last checked: Nov 19, 2026Latest source record: Feb 23, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
240
Planned (sponsor's estimate)
Start
Feb 1, 2021
Primary completion
Apr 30, 2022
Study completion Dec 10, 2022
Sponsor
- Lead sponsor
- Universidade do Vale do SapucaiAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Feb 23, 2022
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Female only, from 20 years, up to 40 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The use of intrauterine device (IUD) in Brazil is still not very significant and one of the reasons is the fear of feeling pain during its insertion procedure. Articaine is an amide-linked local anesthetic, its plasma half-life is shorter than that of most other amide-type anesthetics, which makes it theoretically favorable in relation to systemic toxicity.
Conditions
- Contraception
- IUD
- Anesthesia, Local
Interventions
Articaine Hydrochloride 40 MG/MLDrug
Analysis of uterovaginal plexus block with articain for intrauterine device placement
MepivacaineDrug
Analysis of uterovaginal plexus block with mepivacaine for intrauterine device placement
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pain assessmentTime frame: 15 minutes
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Universidade do Vale do Sapucaí
Pouso Alegre, Minas Gerais, Brazil · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.